Skip to main content

Impax Asset Management Group plc

Position in NBIX — Neurocrine Biosciences Inc

CIK 1749768 LONDON, X0

Position in NBIX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$26,966,400
+$17,085,900 QoQ
Shares Held
160,000
+113.3% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#96
of 768 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Impax Asset Management Group plc holds $79,945,953 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (33.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
160,000 $26,966,400

All Filings in NBIX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,966,400 160,000
2026-03-31 $9,880,500 75,000
2025-12-31 $10,637,250 75,000
2025-09-30 $10,528,500 75,000
2025-06-30 $14,454,350 115,000
2025-03-31 $11,060,000 100,000
2024-12-31 $35,708,263 261,599
2024-09-30 $9,793,700 85,000
2024-06-30 $6,883,500 50,000
2024-03-31 $6,896,000 50,000
2023-12-31 $14,493,600 110,000
2023-09-30 $15,187,500 135,000
2023-06-30 $18,860,000 200,000
2023-03-31 $20,244,000 200,000
2022-12-31 $20,902,000 175,000
2022-09-30 $15,931,500 150,000
2020-03-31 $6,491,250 75,000